Cycle 2: Increased FFA release from adipose tissue in T2DM → FFA influx into the liver → Exacerbates hepatic lipid deposition in MAFLD → Hepatic lipotoxicity further impairs insulin signaling, aggravating systemic IR. The gene discussed is INS; the disease is type 2 diabetes mellitus.